Skip to content
OpenCapital
Get started

Organon OGN EBITDA margin

EBITDA margin at other companies

Pfizer logo
PfizerPFE
25.3%—
Amgen logo
AmgenAMGN
41.5%+3.4pp
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
20.9%-7.3pp
Biogen logo
BiogenBIIB
27%+0.1pp
AbbVie logo
AbbVieABBV
37.3%—
Envista Holdings Corporation logo
Envista Holdings CorporationNVST
10%+5.5pp

Other financials

Income statement

See full
Revenue$1.5B-3.5%
Gross profit$783.0M-6.9%
Net income$146.0M+67.8%
EPS (diluted)$0.55+66.7%

Balance sheet

See full
Cash & equivalents$1.1B+104%
Total debt$8.6B-4.3%
Total equity$903.0M+66.6%
Total assets$13.0B-1.2%

Cash flow

See full
Operating cash flow$225.0M+200%
CapEx$37.0M+15.6%
Free cash flow$188.0M+337%

Valuation

See full
Market cap$3.53B-59.4%

Profitability

See full
Gross margin52.8%-4.4pp
Net margin8%-12.3pp
FCF margin11.1%-1.3pp

Returns & leverage

See full
Return on equity71.6%—
Debt / equity9.5×-7.0×
Current ratio2×+0.3×

Where this comes from

Calculated from Organon’s reported figures.

ebitda/total revenue=21.6%

Based on trailing twelve months.

The official record: Organon’s 10-Q, filed November 10, 2025, on SEC EDGAR. View the filing →

Ask your AI about Organon's ebitda margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Organon's EBITDA margin?
Organon (OGN) reported EBITDA margin of 21.6% in Q3 2025.
How has Organon's EBITDA margin changed year-over-year?
Organon's EBITDA margin decreased by 3.1% year-over-year, from 22.3% to 21.6%.
What is the long-term trend for Organon's EBITDA margin?
Over 4 years (2020 to 2024), Organon's EBITDA margin has grown at a -14.7% compound annual growth rate (CAGR), from 43% to 22.8%.
What does EBITDA margin mean?
EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.